Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 947 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed695    
    Printed46    
    Emailed0    
    PDF Downloaded302    
    Comments [Add]    

Recommend this journal

 
REVIEW ARTICLE
Year : 2004  |  Volume : 46  |  Issue : 3  |  Page : 213-220

Pharmacotherapy of Sexual Dysfunctions : Current Status


1 Additional Prof., Dept. of Psychiatry, Post Graduate Institute of Medical Education & Research, Chandigarh - 160 012, India
2 Senior Resident, Dept. of Psychiatry, Post Graduate Institute of Medical Education & Research, Chandigarh - 160 012, India

Correspondence Address:
Ajith Avasthi
Additional Prof., Dept. of Psychiatry, Post Graduate Institute of Medical Education & Research, Chandigarh - 160 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21224902

Rights and PermissionsRights and Permissions

The sexual dysfunctions are one of the most prevalent conditions. Sexual dysfunctions can have profound effect on the psychological well-being of an individual and the psychosexual relationship of a couple. Management of the sexual dysfunction should be preceded by an accurate diagnosis reached after a complete medical and sexual history and physical examination. Current focus of researchers has been on understanding the pathophysiology of erectile dysfunction, premature ejaculation and other sexual dysfunctions that can help in developing newer pharmacological cures for these conditions. Recently, a number of clinical trials have studied the potential effectiveness of the phosphodiesterase (PDE)-5 inhibitor sildenafil in the treatment of Erectile Dysfunction (ED) and Premature Ejaculation (PME). The introduction of PDE-5 inhibitors like sildenafil, vardenafil and tadalafil has revolutionized the treatment of sexual dysfunctions. This review focuses on the recent pharmacological advances in the treatment of common sexual dysfunctions like ED and PME with special focus on the role of PDE-5 inhibitors. Also discussed is the pharmacological treatment of other less prevalent and recognized disorders like female sexual dysfunction, drug induced sexual dysfunction etc.



[PDF]*

        

Print this article         Email this article